Key result
Deferred stenting after subintimal tracking and reentry (STAR) achieved technical success in 88% of patients with complex coronary chronic total occlusions.
Why the study?
Is deferred stenting following subintimal tracking and reentry (STAR) a safe and effective strategy for complex coronary chronic total occlusions?
Cohort (n=32)
No
Is deferred stenting following subintimal tracking and reentry (STAR) a safe and effective strategy for complex coronary chronic total occlusions?
Deferred stenting after subintimal plaque modification via the STAR technique is a safe and effective strategy for complex CTO lesions when other techniques are prohibitively high risk or have failed.
May support deferred stenting after STAR in select complex CTOs; leaves open confirmation of safety and efficacy in randomized trials.
OBJECTIVES: To determine whether a variation of an abandoned antegrade percutaneous coronary intervention (PCI) technique, termed subintimal tracking and reentry (STAR), could be a safe and effective strategy to contend with complex coronary chronic total occlusions (CTO) when other strategies fail. BACKGROUND: Complex CTOs require advanced techniques such as the retrograde approach, which is associated with higher complication rates than antegrade strategies. METHODS: The medical records of 32 consecutive patients who underwent deferred stenting following STAR (DSS) between January 2015 and May 2017 at a high-volume referral center were retrospectively reviewed. The primary endpoint was technical success at the time of a second procedure following STAR-based balloon angioplasty, defined as successful stenting or the presence of Thrombolysis in Myocardial Infarction Study Group (TIMI) 3 flow with <50% residual stenosis if the vessel caliber was inappropriate for stenting. RESULTS: Of 781 CTO PCI procedures, STAR was performed in 45 (5.8%) and DSS in 32 (4.1%), constituting the analysis cohort. The median Japanese-CTO score was 2.5 [interquartile range (IQR) 1.0-3.0]. Median inter-procedure time was 2.4 months [1.7-3.3 months]. Technical success was achieved in 28 (88%) patients; 23 (72%) patients were treated with stents and 5 (16%) with balloon angioplasty alone. Combined complications included one clinical perforation, one MI, and one stent thrombosis. CONCLUSIONS: Deferred stenting after subintimal plaque modification via the STAR technique is a safe and effective strategy to contend with complex CTO lesions when other techniques are prohibitively high risk or have failed.
No takes yet. Share an insight, caveat, or question.
Goleski et al. (2018) conducted a cohort in Complex coronary chronic total occlusions (CTO) (n=32). Deferred stenting following subintimal tracking and reentry (STAR) was evaluated on Technical success at the time of a second procedure following STAR-based balloon angioplasty. Deferred stenting after subintimal tracking and reentry (STAR) achieved technical success in 88% of patients with complex coronary chronic total occlusions.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: